scispace - formally typeset
J

Jon M. Burnham

Researcher at Children's Hospital of Philadelphia

Publications -  77
Citations -  2581

Jon M. Burnham is an academic researcher from Children's Hospital of Philadelphia. The author has contributed to research in topics: Medicine & Arthritis. The author has an hindex of 26, co-authored 68 publications receiving 2291 citations. Previous affiliations of Jon M. Burnham include Mount Sinai Hospital & University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.

TL;DR: A meta-analysis based on a comprehensive review of the literature in the Medline database and the Cochrane Controlled Trials Register found corticosteroid treatment given early in the course of illness seem to produce consistent benefits for several major clinically relevant Henoch-Schönlein purpura outcomes.
Journal ArticleDOI

Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease.

TL;DR: Substantial deficits in trabecular vBMD, cortical bone geometry, and muscle were observed at Crohn's disease diagnosis andTherapies to improve bone accrual in childhood CD are needed.
Journal ArticleDOI

Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition.

TL;DR: Assessment of whole body BMC in children and young adults with CD and healthy controls found that CD was associated with significant deficits in BMC and lean mass, relative to height and adjustment for lean mass eliminated the bone deficit in CD.
Journal ArticleDOI

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

Adriana Almeida de Jesus, +86 more
TL;DR: The IRG-S expands the diagnostic armamentarium in evaluating USAIDs and points to different pathways regulating IRG expression as well as 3 additional autoinflammatory diseases: IL-18-mediated PAP and recurrent MAS, NEMO∆5-associated autoinflammatory syndrome (NEMO-NDAS), and SAMD9L- associated autoinflammatory disease (SAMD 9L-SAAD).